Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study

Li Yang, Fangli Chen, Hong Liang, Yunsong Bai, Wenzhong Wu, Xiaojing Yan, Jinhai Ren, Si Li, Yang Yu, Laigen Tong, Deng Pan, Ligen Liu

Blood (2023) 142 (Supplement 1): 55.

https://doi.org/10.1182/blood-2023-184581

Published: 2023

Journal Articles

Increase of Dnts Correlated with Clinic Outcome after Allogeneic DNT Cells Infusion in r/r AML Patients

Huiyao Gu, Donghua He, Xiaofeng Han, Yi Li, Li Yang, Enfan Zhang, Haicun Xie, Yu Cheng, Fuqiang Wu, Guangrong Song, Daqing Liu, Liming Yang, Jingsong He, Zhen Cai

Blood (2023) 142 (Supplement 1): 6867.

https://doi.org/10.1182/blood-2023-186221

Published: 2023

Journal Articles

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Blood (2023) 142 (Supplement 1): 2624.

https://doi.org/10.1182/blood-2023-174698

Published: 2023

Journal Articles

The Efficacy of Roxadustat in Multiple Myeloma Patients with Renal Insufficiency and Anemia: A Real-World Study

Shuchan Li, Xiaoyan Han, Gaofeng Zheng, Jingsong He, Wenjun Wu, Yang Yang, Qingxiao Chen, Donghua He, Mengmeng Dong, Jinuo Wang, Yi Li, Li Yang, Zhen Cai

Blood (2023) 142 (Supplement 1): 4726.

https://doi.org/10.1182/blood-2023-184617

Published: 2023

Journal Articles

Venetoclax Combined with Azacitidine Was Effective and Safe for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma: Preliminary Results of a Phase 2, Multicenter Trial

Han-Yu Cao, Lu-Lu Chen, Chao-Ling Wan, Xiao-Hui Hu, Bing Wu, Li Yang, Li Wang, Yang Zhang, De-Pei Wu, Hai-Ping Dai, Hao Zhang, Shengli Xue

Blood (2023) 142 (Supplement 1): 1501.

https://doi.org/10.1182/blood-2023-179733

Published: 2023

Journal Articles

Dietary Behaviors and Social Determinants of Health Among Adults Living with Sickle Cell Disease

Nicole Farmer, Ashley Buscetta, Ralph Tuason, Stephanie Wildridge, Chantal Gerrard, Li Yang, Sara Turner, Shanna Yang, Alyssa Baginski, Faeben Wossenseged, Allison Brichacek, Hasmin C. Ramirez, Vence L. Bonham, Gwenyth R. Wallen

Blood (2023) 142 (Supplement 1): 5131.

https://doi.org/10.1182/blood-2023-174869

Published: 2023

Journal Articles

Innovative Transformer Base Editor (tBE)-Mediated Editing at BCL11A Binding Motif Triggers High Level of γ-Globin Expression with No Observable Off-Target Mutations

Jia Chen, Wenyan Han, Hou-Yuan Qiu, Shangwu Sun, Zhi-Can Fu, Guo-Quan Wang, Li Yang, Bei Yang, Ying Zhang

Blood (2023) 142 (Supplement 1): 7125.

https://doi.org/10.1182/blood-2023-178277

Published: 2023

Journal Articles

Serum Ferritin Increased the Predictive Value of the International Staging System/Revised International Staging System for Overall Survival

Mengmeng Dong, Jinna Zhang, Li Yang, YI LI, Yang Yang, He Huang, Jingsong He, Zhen Cai

Blood (2022) 140 (Supplement 1): 12523.

https://doi.org/10.1182/blood-2022-156742

Published: 2022

Journal Articles

Application of Metagenomic Next Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens from Bronchoalveolar Lavage Samples in Patients Underwent Allogeneic Hematopoietic Stem Cell Transplantation

Jian Yu, Yingying Shi, Yanmin Zhao, Yishan Ye, Huarui Fu, Yi Luo, Xiaoyu Lai, Lizhen Liu, Li Yang, Meng Liu, He Huang, Jimin Shi

Blood (2022) 140 (Supplement 1): 12826–12828.

https://doi.org/10.1182/blood-2022-166049

Published: 2022

Journal Articles

Clinical Efficacy Analysis of the Low-Dose Decitabine in Combination with Cytarabine, All-Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor for Patients with MDS-EB

Ligen Liu, Yuanmmei Zhai, Li Yang, Limin Zhao, Li Chang, Chunrong Yin, Yingting Lu, Xuewei Jiang, Zhizhi Zhang

Blood (2021) 138 (Supplement 1): 3685.

https://doi.org/10.1182/blood-2021-144631

Published: 2021

Journal Articles

The Safety and Efficacy of a CRISPR/Cas9-Engineered Universal CAR-T Cell Product (CTA101) in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Yongxian Hu, MD, Yali Zhou, Mingming Zhang, MD, Wengang Ge, Yi Li, MD, Li Yang, MD, Guoqing Wei, MD, Lu Han, Hao Wang, Xingwang Zhang, PhD, Jiangtao Ren, PhD, He Huang, MD PhD

Blood (2020) 136 (Supplement 1): 52.

https://doi.org/10.1182/blood-2020-142262

Published: 2020

Journal Articles

The Efficacy and Safety of Decitabine in Combination with ATRA, G-CSF and Low Dose Cytarabine(Dlaag Regimen)in Relapsed/Refractory Acute Myeloid Leukemia Not Suitable for Strong Chemotherapy : A Phase 2, Prospective, Single-Arm, Multicenter Study

Li Yang, Ligen Liu, Limin Zhao, Yingting Lu, Jing Zhang, Lihua Sun

Blood (2019) 134 (Supplement_1): 5108.

https://doi.org/10.1182/blood-2019-131671

Published: 2019

Journal Articles

The Efficacy and Safety of Cladribine in Combination with Cytarabine ,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study

Tinghua Zhang, Yinghua Xie, Limin Zhao, Xiyao Han, Yingting Lu, Jing Zhang, Yanhui Xie, Qi Zhu, Lihua Sun, Li Yang, Ligen Liu

Blood (2019) 134 (Supplement_1): 3843.

https://doi.org/10.1182/blood-2019-125739

Published: 2019

Journal Articles

Diplotype Analysis of NUDT15 Variants By Targeted Sequencing in Pediatric Acute Lymphoblastic Leukemia

Chih-Hsiang Yu, Ya-Hsuan Chang, PhD, Wen-Chien Chou, MD, PhD, Der-Shiun Wang, MD, Shu-Wha Lin, PhD, Hsuan-Yu Chen, PhD, Yung-Li Yang, MD PhD

Blood (2019) 134 (Supplement_1): 1305.

https://doi.org/10.1182/blood-2019-124053

Published: 2019

Journal Articles

Clinical and Genetic Features of Epstein-Barr Virus-Triggered Late-Onset Primary Hemophagocytic Lymphohistiocytosis: 10 Pedigrees Study

Chunrui Li, MD PhD, Lili Gao, Li Yang, Min Xiao, MD PhD, Jianfeng Zhou, MD PhD, Yicheng Zhang, MD PhD

Blood (2018) 132 (Supplement 1): 3903.

https://doi.org/10.1182/blood-2018-99-114009

Published: 2018

Journal Articles

The Novel Subtype-Selective Histone Deacetylase (HDAC) Inhibitor, Chidamide, Exerts Dual Anti-Myeloma and Bone Protective Effect in Vitro and In Vivo

Jingsong He, MD, Qingxiao Chen, MS, Yang Yang, MD, Yi Li, MD, Li Yang, MD, He Huang, MD PhD, Qing Yi, MD PhD, Zhen Cai, MD PhD

Blood (2017) 130 (Supplement 1): 5392.

https://doi.org/10.1182/blood.V130.Suppl_1.5392.5392

Published: 2017

Journal Articles

Adjusting Dosage of Mercaptopurine By NUDT15 Polymorphisms in Childhood Acute Lymphoblastic Leukemia

Der-Shiun Wang, MD, Chih-Hsiang Yu, Ph. D student, Wen-Chien Chou, MD, PhD, Ya-Hsuan Chang, Chien-Yu Lin, Kai-Hsin Lin, Shiann-Tarng Jou, MD PhD, Meng Yao Lu, MD, Hsiu-Hao Chang, MD PhD, Shu-Wha Lin, PhD, Dong-Tsamn Lin, Professor, Hsuan-Yu Chen, Ph. D, Yung-Li Yang, MD PhD

Blood (2017) 130 (Supplement 1): 2566.

https://doi.org/10.1182/blood.V130.Suppl_1.2566.2566

Published: 2017

Journal Articles

Genetic Profiling in Childhood T-Cell Acute Lymphoblastic Leukemia By Targeted Sequencing

Chih-Hsiang Yu, Ph. D student, Ya-Hsuan Chang, Wen-Chien Chou, MD, PhD, Shiann-Tarng Jou, MD PhD, Meng Yao Lu, MD, Hsiu-Hao Chang, MD PhD, Shu-Wha Lin, PhD, Dong-Tsamn Lin, Professor, Hsuan-Yu Chen, Ph. D, Der-Shiun Wang, MD, Yung-Li Yang, MD PhD

Blood (2017) 130 (Supplement 1): 1289.

https://doi.org/10.1182/blood.V130.Suppl_1.1289.1289

Published: 2017

Journal Articles

Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry

Takaya Moriyama, Yung-Li Yang, Rina Nishii, Hany Ariffin, Chengcheng Liu, Ting-Nien Lin, Wenjian Yang, Dong-Tsamn Lin, Chih-Hsiang Yu, Shirley Kham, Ching-Hon Pui, William E. Evans, Sima Jeha, Mary V. Relling, Allen Eng-Juh Yeoh, Jun J. Yang

Blood (2017) 130 (10): 1209–1212.

https://doi.org/10.1182/blood-2017-05-782383

Published: 2017

Includes: Supplemental data

Journal Articles

Interleukin-32 Induce Production of IL-6 in Multiple Myeloma Bone Marrow Stromal Cells

Xuanru Lin, M.MD, Xing Guo, M.MD, Jing Chen, M.MD, Qingxiao Chen, M.MD, Enfan Zhang, M.MD, Yi Li, PhD, Li Yang, PhD, Jingsong He, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 3253.

https://doi.org/10.1182/blood.V128.22.3253.3253

Published: 2016

NARROW

Selinexor in Combination with Venetoclax and Azacitidine for Newly Diagnosed (ND) Unfit Acute Myeloid Leukemia (AML): A Multicenter, Open-Label Prospective Study

Increase of Dnts Correlated with Clinic Outcome after Allogeneic DNT Cells Infusion in r/r AML Patients

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

The Efficacy of Roxadustat in Multiple Myeloma Patients with Renal Insufficiency and Anemia: A Real-World Study

Venetoclax Combined with Azacitidine Was Effective and Safe for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma: Preliminary Results of a Phase 2, Multicenter Trial

Dietary Behaviors and Social Determinants of Health Among Adults Living with Sickle Cell Disease

Innovative Transformer Base Editor (tBE)-Mediated Editing at BCL11A Binding Motif Triggers High Level of γ-Globin Expression with No Observable Off-Target Mutations

Serum Ferritin Increased the Predictive Value of the International Staging System/Revised International Staging System for Overall Survival

Application of Metagenomic Next Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens from Bronchoalveolar Lavage Samples in Patients Underwent Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Efficacy Analysis of the Low-Dose Decitabine in Combination with Cytarabine, All-Trans Retinoic Acid and Granulocyte Colony-Stimulating Factor for Patients with MDS-EB

The Safety and Efficacy of a CRISPR/Cas9-Engineered Universal CAR-T Cell Product (CTA101) in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

The Efficacy and Safety of Decitabine in Combination with ATRA, G-CSF and Low Dose Cytarabine(Dlaag Regimen)in Relapsed/Refractory Acute Myeloid Leukemia Not Suitable for Strong Chemotherapy : A Phase 2, Prospective, Single-Arm, Multicenter Study

The Efficacy and Safety of Cladribine in Combination with Cytarabine ,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study

Diplotype Analysis of NUDT15 Variants By Targeted Sequencing in Pediatric Acute Lymphoblastic Leukemia

Clinical and Genetic Features of Epstein-Barr Virus-Triggered Late-Onset Primary Hemophagocytic Lymphohistiocytosis: 10 Pedigrees Study

The Novel Subtype-Selective Histone Deacetylase (HDAC) Inhibitor, Chidamide, Exerts Dual Anti-Myeloma and Bone Protective Effect in Vitro and In Vivo

Adjusting Dosage of Mercaptopurine By NUDT15 Polymorphisms in Childhood Acute Lymphoblastic Leukemia

Genetic Profiling in Childhood T-Cell Acute Lymphoblastic Leukemia By Targeted Sequencing

Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry

Interleukin-32 Induce Production of IL-6 in Multiple Myeloma Bone Marrow Stromal Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only